Moleculin Biotech, Inc. MBRX
- Annamycin — Pancreatic Cancer
CD8+ T cells (2 companies · 2 programs)
Companies with an active program directed at CD8+ T cells.
SAB Biotherapeutics, Inc. SABS
- SAB-142 — Type 1 Diabetes Phase 2
Companies with an active program directed at CD8+ T cells.